WGS — GeneDx Holdings Corp.
—
Nasdaq ·
Health Care ·
Health Care Providers & Services ·
CIK 1818331 ·
Last close
$65.11
Market Cap
$1.93B
52W High
$72.95
52W Low
$32.21
ADV30
784,787
Next earnings
2026-08-03
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 102,254,000 | 68,211,000 | -26,184,000 | -63,316,000 | 506,301,000 | 93,924,000 | 252,177,000 |
| Dec 2025 | 120,989,000 | 84,268,000 | -14,235,000 | -17,666,000 | 523,710,000 | 104,997,000 | 215,528,000 |
| Sep 2025 | 116,743,000 | 84,527,000 | -3,251,000 | -7,635,000 | 493,902,000 | 95,968,000 | 201,644,000 |
| Jun 2025 | 102,692,000 | 70,902,000 | 8,960,000 | 10,809,000 | 463,863,000 | 74,120,000 | 186,730,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-9,311,000
Investing CF
$-69,364,000
Financing CF
$72,897,000
CapEx
$-19,341,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-2.30
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-1,436,811,000
Inventory
$12,241,000
Receivables
$76,929,000
ST Investments
$76,761,000
EBIT TTM
$-67,808,000
Pretax Income TTM
$-77,474,000
Interest Exp TTM
$2,174,000
Analysts
9
Yahoo Snapshot (yfinance, live)
Total Revenue
$442,678,016
EBITDA
$-7,850,000
Free Cash Flow
$3,643,375
Enterprise Value
$1,930,494,464
Total Cash
$170,684,992
Total Debt
$168,192,000
Shares Out
29,688,027
Trailing EPS
$-2.66
Book Value
$8.57
ROE
-30.4%
ROA
-4.4%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 427,539,000 | -13,077,000 | -21,021,000 | 523,710,000 | 215,528,000 | — | 33,279,000 |
| Dec 2024 | 305,450,000 | -23,213,000 | -52,286,000 | 419,380,000 | 174,133,000 | — | -28,496,000 |
| Dec 2023 | 202,566,000 | -170,194,000 | -175,767,000 | 418,756,000 | 190,739,000 | — | -180,147,000 |
| Dec 2022 | 234,694,000 | -457,507,000 | -548,980,000 | 490,942,000 | 237,237,000 | — | -319,155,000 |
TTM Snapshot
Revenues TTM
$256,589,000
NetIncome TTM
$-95,448,000
OpCashFlow TTM
$0
Assets (Latest)
$419,380,000
Forward EPS
$1.10
Max Pain — expiry 2026-09-18
max pain strike: $50.00 · spot: $65.11 · call oi: 2,361 · put oi: 469
Expected Move to 2026-09-18:
±$17.90
(27.49%) —
implied range
$47.21 –
$83.01
· ATM straddle on $65.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| SNDA | SONIDA SENIOR LIVING, INC. | $1.91B | $40.36 | — |
| SGRY | Surgery Partners, Inc. | $2.01B | $15.40 | — |
| AVAH | Aveanna Healthcare Holdings, Inc. | $2.04B | $9.39 | — |
| FTRE | Fortrea Holdings Inc. | $1.82B | $19.17 | — |
| ADUS | Addus HomeCare Corp | $2.16B | $115.48 | — |
News headlines (Yahoo Finance, 1h cache)
GeneDx Holdings Corp. (WGS) Slid as Revenue Fell Short of Expectations
2026-07-21 14:04 · Yahoo
GeneDx Holdings Corp. (WGS) Fell Following a Significant Cut in 2026 Guidance
2026-07-17 13:11 · Yahoo
GeneDx to Report Second Quarter 2026 Financial Results on Monday, August 3, 2026
2026-07-16 20:05 · Yahoo
What a $227,000 GeneDx Insider Sale Means as Revenue Climbs 17%
2026-06-23 22:08 · Yahoo
Hedge Funder Eli Casdin Is Loading up on GeneDx Shares
2026-06-11 15:01 · Yahoo
GeneDx Holdings (WGS) Valuation After Q1 2026 Earnings Miss Guidance Cut And Legal Scrutiny
2026-06-06 13:19 · Yahoo
From Industry Titans to Tiny Fish: 3 Key Stocks Insiders are Trading
2026-06-06 12:05 · Yahoo
This Healthcare Investor Added $43 Million to a Genomics Leader Growing Volume 34%
2026-05-23 20:37 · Yahoo
Ashland, GeneDX Holdings, and 3 More Stocks See Action From Activist Investors
2026-05-22 22:23 · Yahoo
Is GeneDx Stock a Buys After a Company Director Purchased Over 350,000 Shares?
2026-05-21 14:43 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.